Improving Our Understanding of Driving Changes in Preclinical and Early Symptomatic Alzheimer's Disease: The Role of Naturalistic Driving Studies

Catherine M. Roe

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Research on how preclinical and early symptomatic Alzheimer's disease (AD) impacts driving behavior is in its infancy, with several important research areas yet to be explored. This paper identifies research gaps and suggests priorities for driving studies over the next few years among those at the earliest stages of AD. These priorities include how individual differences in demographic and biomarker measures of AD pathology, as well as differences in the in-vehicle and external driving environment, affect driving behavior. Understanding these differences is important to developing future interventions to increase driving safety among those at the earliest stages of AD.

Original languageEnglish
Pages (from-to)521-528
Number of pages8
JournalJournal of Alzheimer's Disease Reports
Volume6
Issue number1
DOIs
StatePublished - 2022

Keywords

  • biomarkers
  • driving
  • early Alzheimer's disease
  • mild cognitive impairment
  • preclinical Alzheimer's disease

Fingerprint

Dive into the research topics of 'Improving Our Understanding of Driving Changes in Preclinical and Early Symptomatic Alzheimer's Disease: The Role of Naturalistic Driving Studies'. Together they form a unique fingerprint.

Cite this